–
TScan Therapeutics, Inc.
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
millions USD
FY21:
FY22:
–
FY23:
–
FY24:
–
FY25:
–
(positive)
Change from FY21 to FY25
millions USD
FY21:
−48.6
FY22:
−66.6
FY23:
−93.5
FY24:
−135
FY25:
−136
(positive)
Change from FY21 to FY25
millions USD
FY21:
−45.3
FY22:
−59.9
FY23:
−80.1
FY24:
−119
FY25:
−124
(positive)
Change from FY21 to FY25
millions USD
FY21:
−48.6
FY22:
−66.2
FY23:
−89.2
FY24:
−127
FY25:
−130
(positive)
Change from FY21 to FY25
millions USD
FY21:
−48.6
FY22:
−66.2
FY23:
−89.2
FY24:
−127
FY25:
−130
All amounts in millions USD